206 related articles for article (PubMed ID: 30251170)
1. Development and pilot testing of a leaflet informing women with breast cancer about genomic testing for polygenic risk.
Kaur R; Meiser B; Yanes T; Young MA; Barlow-Stewart K; Roscioli T; Smith S; James PA
Fam Cancer; 2019 Apr; 18(2):147-152. PubMed ID: 30251170
[TBL] [Abstract][Full Text] [Related]
2. Psychosocial and behavioral impact of breast cancer risk assessed by testing for common risk variants: protocol of a prospective study.
Yanes T; Meiser B; Young MA; Kaur R; Mitchell G; Barlow-Stewart K; Roscioli T; Halliday J; James P
BMC Cancer; 2017 Jul; 17(1):491. PubMed ID: 28720130
[TBL] [Abstract][Full Text] [Related]
3. Women's responses and understanding of polygenic breast cancer risk information.
Yanes T; Kaur R; Meiser B; Scheepers-Joynt M; McInerny S; Barlow-Stewart K; Antill Y; Salmon L; Smyth C; James PA; Young MA
Fam Cancer; 2020 Oct; 19(4):297-306. PubMed ID: 32430685
[TBL] [Abstract][Full Text] [Related]
4. Development and Pilot Testing of a Decision Aid for Genomic Research Participants Notified of Clinically Actionable Research Findings for Cancer Risk.
Willis AM; Smith SK; Meiser B; Ballinger ML; Thomas DM; Tattersall M; ; ; Young MA
J Genet Couns; 2018 Sep; 27(5):1055-1066. PubMed ID: 29455319
[TBL] [Abstract][Full Text] [Related]
5. A literature review of the psychological impact of genetic testing on breast cancer patients.
Schlich-Bakker KJ; ten Kroode HF; Ausems MG
Patient Educ Couns; 2006 Jul; 62(1):13-20. PubMed ID: 16242293
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer genetic counseling after diagnosis but before treatment: a pilot study on treatment consequences and psychological impact.
Wevers MR; Hahn DE; Verhoef S; Bolhaar MD; Ausems MG; Aaronson NK; Bleiker EM
Patient Educ Couns; 2012 Oct; 89(1):89-95. PubMed ID: 22543000
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of early diagnosis and treatment in women with a family history of breast cancer. European Familial Breast Cancer Collaborative Group.
Møller P; Reis MM; Evans G; Vasen H; Haites N; Anderson E; Steel CM; Apold J; Lalloo F; Maehle L; Preece P; Gregory H; Heimdal K
Dis Markers; 1999 Oct; 15(1-3):179-86. PubMed ID: 10595275
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of a general information leaflet for women with a family history of breast cancer.
Andermann AA; Austoker J; Watson EK; Lucassen AM; Mackay J
J Cancer Educ; 2002; 17(3):155-60. PubMed ID: 12243221
[TBL] [Abstract][Full Text] [Related]
9. Genetic testing by cancer site: breast.
Shannon KM; Chittenden A
Cancer J; 2012; 18(4):310-9. PubMed ID: 22846731
[TBL] [Abstract][Full Text] [Related]
10. Hereditary breast cancer syndromes and genetic testing.
Rich TA; Woodson AH; Litton J; Arun B
J Surg Oncol; 2015 Jan; 111(1):66-80. PubMed ID: 25381882
[TBL] [Abstract][Full Text] [Related]
11. Cancer surveillance behaviors in women presenting for clinical BRCA genetic susceptibility testing.
Loescher LJ; Lim KH; Leitner O; Ray J; D'Souza J; Armstrong CM
Oncol Nurs Forum; 2009 Mar; 36(2):E57-67. PubMed ID: 19273395
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer.
Møller P; Evans G; Haites N; Vasen H; Reis MM; Anderson E; Apold J; Hodgson S; Eccles D; Olsson H; Stoppa-Lyonnet D; Chang-Claude J; Morrison PJ; Bevilacqua G; Heimdal K; Maehle L; Lalloo F; Gregory H; Preece P; Borg A; Nevin NC; Caligo M; Steel CM
Dis Markers; 1999 Oct; 15(1-3):207-11. PubMed ID: 10595280
[TBL] [Abstract][Full Text] [Related]
13. Universal genetic testing for women with newly diagnosed breast cancer in the context of multidisciplinary team care.
De Silva DL; Stafford L; Skandarajah AR; Sinclair M; Devereux L; Hogg K; Kentwell M; Park A; Lal L; Zethoven M; Jayawardana MW; Chan F; Butow PN; James PA; Mann GB; Campbell IG; Lindeman GJ
Med J Aust; 2023 May; 218(8):368-373. PubMed ID: 37005005
[TBL] [Abstract][Full Text] [Related]
14. Acceptability of, and Information Needs Regarding, Next-Generation Sequencing in People Tested for Hereditary Cancer: A Qualitative Study.
Meiser B; Storey B; Quinn V; Rahman B; Andrews L
J Genet Couns; 2016 Apr; 25(2):218-27. PubMed ID: 26259529
[TBL] [Abstract][Full Text] [Related]
15. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J
Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680
[TBL] [Abstract][Full Text] [Related]
16. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
17. Genetic testing for familial breast cancer--ethical questions concerning individual rights and social responsibility.
Graumann S
Dis Markers; 1999 Oct; 15(1-3):136-8. PubMed ID: 10595267
[No Abstract] [Full Text] [Related]
18. Impact of BRCA1 testing on women with cancer: a pilot study.
Wood ME; Mullineaux L; Rahm AK; Fairclough D; Wenzel L
Genet Test; 2000; 4(3):265-72. PubMed ID: 11142757
[TBL] [Abstract][Full Text] [Related]
19. Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast Cancer.
Chang-Claude J; Becher H; Caligo M; Eccles D; Evans G; Haites N; Hodgson S; Møller P; Weber BH; Stoppa-Lyonnet D
Dis Markers; 1999 Oct; 15(1-3):53-65. PubMed ID: 10595253
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer risk assessment in patients who test negative for a hereditary cancer syndrome.
Breit C; Ablah E; Ward M; Okut H; Tenofsky PL
Am J Surg; 2020 Mar; 219(3):430-433. PubMed ID: 31635794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
